Cargando…

Unexpected interactions between dolutegravir and folate: randomized trial evidence from South Africa

Dolutegravir exposure at conception was associated with a preliminary signal of increased infant neural tube defect risk. As low maternal folate levels are linked with neural tube defects, we aimed to assess serum folate concentrations in women starting dolutegravir. DESIGN: We analysed serum folate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chandiwana, Nomathemba C., Chersich, Matthew, Venter, W.D. François, Akpomiemie, Godspower, Hill, Andrew, Simmons, Bryony, Lockman, Shahin, Serenata, Celicia M., Fairlie, Lee, Moorhouse, Michelle A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810415/ https://www.ncbi.nlm.nih.gov/pubmed/33086234 http://dx.doi.org/10.1097/QAD.0000000000002741

Ejemplares similares

Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
por: Siedner, Mark J., et al.
Publicado: (2020)

CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz
por: Griesel, Rulan, et al.
Publicado: (2020)

Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?
por: Fairlie, Lee, et al.
Publicado: (2019)

Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial
por: Venter, Willem D. F., et al.
Publicado: (2017)

High loss to follow-up of children on antiretroviral treatment in a primary care HIV clinic in Johannesburg, South Africa
por: Chandiwana, Nomathemba, et al.
Publicado: (2018)

Concentration-Response Relationships of Dolutegravir and Efavirenz with Weight Change After Starting Antiretroviral Therapy
por: Griesel, Rulan, et al.
Publicado: (2022)

Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV
por: Mondleki, Enkosi, et al.
Publicado: (2022)

Phase 3 trials of new antiretrovirals are not representative of the global HIV epidemic
por: Pepperrell, Toby, et al.
Publicado: (2020)

The ADVANCE study: a groundbreaking trial to evaluate a candidate universal antiretroviral regimen
por: Venter, Willem D.F., et al.
Publicado: (2017)

Treatment And Prevention for female Sex workers in South Africa: protocol for the TAPS Demonstration Project
por: Gomez, Gabriela B, et al.
Publicado: (2016)

Weight gain on dolutegravir: Association is not the same as causation
por: Maartens, Gary, et al.
Publicado: (2023)

Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection
por: Sokhela, Simiso, et al.
Publicado: (2022)

Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial
por: Venter, Willem Daniel Francois, et al.
Publicado: (2019)

1498. Geographic differences in weight change on dolutegravir: a prospective cohort study
por: Chen, Geoffrey, et al.
Publicado: (2023)

Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa
por: Sokhela, Simiso, et al.
Publicado: (2022)

The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis
por: Phillips, Andrew N, et al.
Publicado: (2021)

Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa
por: Mokgethi, Nomcebo Oratile, et al.
Publicado: (2022)

Impact of rilpivirine cross-resistance on long-acting cabotegravir-rilpivirine in low and middle-income countries
por: Steegen, Kim, et al.
Publicado: (2023)

Folate receptor-targeted near-infrared photodynamic therapy for folate receptor-overexpressing tumors
por: Aung, Winn, et al.
Publicado: (2022)

Interaction between dolutegravir and folate transporters and receptor in human and rodent placenta
por: Gilmore, Julian C., et al.
Publicado: (2021)

Views of Medical Doctors Regarding the 2013 WHO Adult HIV Treatment Guidelines Indicate Variable Applicability for Routine Patient Monitoring, for Their Family Members and for Themselves, in South-Africa
por: Venter, Willem Daniel Francois, et al.
Publicado: (2016)

I don’t know what I am doing because I am doing everything: perceptions and experiences of nurses about HIV counselling and testing among children in Free State Province, South Africa
por: Olaleye, Abiola O., et al.
Publicado: (2016)

Tracking adverse drug reactions and medication errors in the Central Chronic Medicine Dispensing and Distribution (CCMDD) programme in South Africa
por: Otwombe, Kennedy, et al.
Publicado: (2022)

Risks of metabolic syndrome in the ADVANCE and NAMSAL trials
por: Tovar Sanchez, Tamara, et al.
Publicado: (2023)

Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial
por: Griesel, Rulan, et al.
Publicado: (2023)

Patterns of Immune Activation in HIV and Non HIV Subjects and Its Relation to Cardiovascular Disease Risk
por: Vos, Alinda G., et al.
Publicado: (2021)

Folate deficiency increases the incidence of dolutegravir-associated foetal defects in a mouse pregnancy model
por: Mohan, Haneesha, et al.
Publicado: (2023)

Imaging of Folate Receptor Expressing Macrophages in the Rat Groove Model of Osteoarthritis: Using a New DOTA-Folate Conjugate
por: de Visser, Huub M., et al.
Publicado: (2017)

Initial Supplementary Dose of Dolutegravir in Second-Line Antiretroviral Therapy: A Noncomparative, Double-Blind, Randomized Placebo-Controlled Trial
por: Zhao, Ying, et al.
Publicado: (2023)

Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy
por: Moorhouse, Michelle A., et al.
Publicado: (2018)

Community-based management of a five-arm randomised clinical trial in COVID-19 outpatients in South Africa: challenges and opportunities
por: Chandiwana, Nomathemba, et al.
Publicado: (2023)

Weight gain during pregnancy among women initiating dolutegravir in Botswana
por: Caniglia, Ellen C., et al.
Publicado: (2020)

Dolutegravir resistance in three pregnant and breastfeeding women in South Africa
por: Fourie, Ninke, et al.
Publicado: (2023)

Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
por: Phillips, Andrew N, et al.
Publicado: (2018)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
por: Kawuma, Aida N., et al.
Publicado: (2023)

Folate Receptor Expression by Human Monocyte–Derived Macrophage Subtypes and Effects of Corticosteroids
por: Warmink, Kelly, et al.
Publicado: (2022)

Polymorphisms in MTHFR, MTR, RFC1 and CßS genes involved in folate metabolism and thyroid cancer: a case-control study
por: Zara-Lopes, Tairine, et al.
Publicado: (2019)

Impacts of Climate Change on Health and Wellbeing in South Africa
por: Chersich, Matthew F., et al.
Publicado: (2018)

Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study
por: Zash, Rebecca, et al.
Publicado: (2018)

Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans
por: Mateza, Somila, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nogc89p6ldfai8sc3f4surn3mn